This company provides the CloudANS™ platform, which converts data from everyday wearables into continuous autonomic nervous system (ANS) monitoring. The platform reveals system-level dysfunction upstream of symptoms, enabling personalized, longitudinal care for complex conditions. It offers clinical-grade autonomic testing and interpretation to support root-cause treatment and homeostasis management.
Funding
Funding not disclosed
Founders
Product
Problem
Late-stage diagnosis of cardiovascular diseases limits effective intervention and worsens patient outcomes. Current diagnostic methods often fail to detect early warning signs, resulting in delayed treatment and increased mortality. Continuous monitoring of the autonomic nervous system, which regulates key cardiovascular functions, could enable earlier detection but requires advanced analytical capabilities.
Solution
Autonomic Health is developing an AI-driven platform that continuously monitors the autonomic nervous system using data from consumer wearables to enable early detection of diseases, starting with cardiovascular conditions. The platform leverages an advanced AI model to analyze wearable sensor data, providing real-time insights into autonomic nervous system activity. By continuously monitoring this critical system, Autonomic Health aims to identify subtle changes indicative of early-stage cardiovascular disease, allowing for timely intervention and improved patient outcomes. The system provides personalized interventions based on the detected anomalies.
Target Audience
The primary target audience includes individuals at risk of cardiovascular disease and healthcare providers seeking advanced diagnostic tools for early disease detection.
Features
- Continuous monitoring of the autonomic nervous system using consumer wearable data
- AI-powered analysis of sensor data to detect early signs of cardiovascular disease
- Real-time insights into autonomic nervous system activity
- Personalized interventions based on detected anomalies